INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 45h ago
House PTR5h ago
SEC 13F5h ago
Robinhood Chain5h ago

Results

74,196 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
OC
O'Connor CaseyChief Legal Officer
SFIXStitch Fix, Inc.
Option exercise
M—
25.3K sh
Sep 16, 2026Sep 18, 2026
Page 400 of 1855
← PrevNext →
traded Sep 16, 2026
+2d
SEC Form 4

Evidence

9
LF
Lo FrancisChief People Officer
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$645K
53.1K sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

9
GT
Goldthwaite ToddMANAGING DIRECTOR
LRNStride, Inc.
Option exercise
M—
1,840 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

9
RE
Ridloff ElenaCFO and CBO
SIONSionna Therapeutics, Inc.
Disposition to issuer
D—
165.4K sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

9
FJ
Fullalove Craig JeffreyCFO
WYNNWYNN RESORTS LTD
Grant or award
A—
3,414 sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

9
GT
Goldthwaite ToddMANAGING DIRECTOR
LRNStride, Inc.
Option exercise
M—
1,840 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

9
AT
Allen William TDirector
SVVSavers Value Village, Inc.
Option exercise
M$23K
7,135 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

9
GA
Gold Daniel AllenDirector
ROIVRoivant Sciences Ltd.
Grant or award
A—
5,054 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

9
LT
Leech Christopher T.Director
SLMSLM Corp
Grant or award
A—
914 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

9
WL
Wang LingkeDirector, President
LIFEEthos Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$285K
7,431 sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

9
CT
Carl Drew ThomasChief Accounting Officer
HLNEHamilton Lane INC
Grant or award
A—
2,226 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

9
BD
Blackman DonnaCHIEF FINANCIAL OFFICER
LRNStride, Inc.
Option exercise
M—
12.9K sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

9
CM
Cloonan MichaelDirector, President & CEO
SIONSionna Therapeutics, Inc.
Disposition to issuer
D—
436.1K sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

9
SR
Sullivan Christopher RyanChief Financial Officer
AVTXAvalo Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$202K
12.4K sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

9
MC
McKee CharlotteCMO and Head of R&D
SIONSionna Therapeutics, Inc.
Grant or award
A—
155.7K sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

9
MC
McKee CharlotteCMO and Head of R&D
SIONSionna Therapeutics, Inc.
Disposition to issuer
D—
155.7K sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

9
GS
George Matthew SpencerDirector, Chief Executive Officer
MRLNMerlin, Inc.
Tax withholding
F$3,244
1,468 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

9
GA
Gold Daniel AllenDirector
ROIVRoivant Sciences Ltd.
Grant or award
A—
10.5K sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

9
HJ
Hazelbaker JillSee Remarks
UBERUber Technologies, Inc
Option exercise
M—
1,493 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

9
CG
Colis Peter GeorgeDirector, CEO and Secretary
LIFEEthos Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$850K
21.4K sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

9
AB
Armbrister Jeffrey BrianChief Financial Officer
HLNEHamilton Lane INC
Tax withholding
F$37K
393 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

9
MA
Macdonald AndrewSee Remarks
UBERUber Technologies, Inc
Option exercise
M—
2,519 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

9
PL
Parks Diane L.Director
SNGXSOLIGENIX, INC.
Grant or award
A—
78.9K sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

9
CG
Colis Peter GeorgeDirector, CEO and Secretary
LIFEEthos Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$357K
9,648 sh
Sep 18, 2026Sep 18, 2026
traded Sep 18, 2026
+0dSEC Form 4

Evidence

9
CG
Colis Peter GeorgeDirector, CEO and Secretary
LIFEEthos Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$259K
7,190 sh
Sep 18, 2026Sep 18, 2026
traded Sep 18, 2026
+0dSEC Form 4

Evidence

9
BK
Budur KumarCHIEF MEDICAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Option exercise
M$28K
900 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

9
FT
Fuchs ThomasDirector
WGSGeneDx Holdings Corp.
Option exercise
M—
1,146 sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

9
SK
Stueland KatherineDirector, CHIEF EXECUTIVE OFFICER
WGSGeneDx Holdings Corp.
Option exercise
M—
18.8K sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

9
EB
Epperly Melissa B,Director
ROIVRoivant Sciences Ltd.
Grant or award
A—
10.5K sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

9
BS
Billings Craig ScottDirector, CEO
WYNNWYNN RESORTS LTD
Grant or award
A—
4,228 sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

9
KA
Krishnamurthy Balaji (A)Chief Financial Officer
UBERUber Technologies, Inc
Option exercise
M—
1,158 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

9
AB
Armbrister Jeffrey BrianChief Financial Officer
HLNEHamilton Lane INC
Grant or award
A—
22.3K sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

9
KA
Krishnamurthy Balaji (A)Chief Financial Officer
UBERUber Technologies, Inc
Option exercise
M—
606 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

9
BD
Blackman DonnaCHIEF FINANCIAL OFFICER
LRNStride, Inc.
Grant or award
A—
4,834 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

9
LL
Lavelle Mark LDirector
SLMSLM Corp
Grant or award
A—
1,038 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

9
BS
Billings Craig ScottDirector, CEO
WYNNWYNN RESORTS LTD
Grant or award
A—
8,535 sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

9
BK
Budur KumarCHIEF MEDICAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Option exercise
M$27K
900 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

9
KA
Kramer Andrea AnigatiChief Operating Officer, 10% Owner
HLNEHamilton Lane INC
Grant or award
A—
22.3K sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

9
FJ
Fullalove Craig JeffreyCFO
WYNNWYNN RESORTS LTD
Grant or award
A—
1,691 sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

9
RR
Ravestein Leslie ReneeCLO and Secretary
MRLNMerlin, Inc.
Tax withholding
F$2,433
1,101 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence